Eisai invests $15m in C₂N Diagnostics to advance Alzheimer’s disease diagnostics
In a significant move for the field of brain health diagnostics, C₂N Diagnostics, LLC, a pioneer in developing advanced diagnostic solutions for Alzheimer’s disease, has secured an investment of up to $15 million from Eisai Inc., a globally recognized human health care company. This strategic partnership underscores a shared commitment between the two firms to […]